Imetelstat, a telomerase inhibitor, is capable of depleting myelofibrosis stem and progenitor cells

about

Imetelstat, a telomerase inhibitor, is capable of depleting myelofibrosis stem and progenitor cells

Item

http://www.wikidata.org/entity/Q58705137

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Imetelstat, a telomerase inhib ...... osis stem and progenitor cells

@en

Imetelstat, a telomerase inhib ...... osis stem and progenitor cells

@nl

type

Item

label

Imetelstat, a telomerase inhib ...... osis stem and progenitor cells

@en

Imetelstat, a telomerase inhib ...... osis stem and progenitor cells

@nl

prefLabel

Imetelstat, a telomerase inhib ...... osis stem and progenitor cells

@en

Imetelstat, a telomerase inhib ...... osis stem and progenitor cells

@nl

P1476

Imetelstat, a telomerase inhib ...... osis stem and progenitor cells

@en

P2093

Bruce Petersen

http://www.w3.org/2001/XMLSchema#string

Cing Siang Hu

http://www.w3.org/2001/XMLSchema#string

Fei Huang

http://www.w3.org/2001/XMLSchema#string

Fei Ye

http://www.w3.org/2001/XMLSchema#string

Jane Houldsworth

http://www.w3.org/2001/XMLSchema#string

Jiajing Qiu

http://www.w3.org/2001/XMLSchema#string

Kevin Eng

http://www.w3.org/2001/XMLSchema#string

Ronald Hoffman

http://www.w3.org/2001/XMLSchema#string

Xiaoli Wang

http://www.w3.org/2001/XMLSchema#string

P2860

The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2

Erlotinib effectively inhibits JAK2V617F activity and polycythemia vera cell growth

Specific association of human telomerase activity with immortal cells and cancer

Identification of a specific telomere terminal transferase activity in Tetrahymena extracts

CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons

Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia.

Telomere maintenance in laser capture microdissection-purified Barrett's adenocarcinoma cells and effect of telomerase inhibition in vivo.

JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis.

A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis.

P304

2378-2388

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOODADVANCES.2018022012

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30242099

http://www.w3.org/2001/XMLSchema#string

P932

6156882

http://www.w3.org/2001/XMLSchema#string